Is intravesical chemotherapy for superficial bladder cancer still justified? - Wikidata - wikimedia - TriplyDB

Is intravesical chemotherapy for superficial bladder cancer still justified?

Is intravesical chemotherapy for superficial bladder cancer still justified?

http://www.wikidata.org/entity/Q36253605

about

Intravesical Bacillus Calmette-Guérin versus epirubicin for Ta and T1 bladder cancer Intravesical mitomycin C for superficial transitional cell carcinoma.Paclitaxel and cisplatin as intravesical agents against non-muscle-invasive bladder cancer.

P2860

Q24234614-C976B149-701B-4F36-9D07-F43BDCCD2680 Q36573853-BDFE4193-CC67-4561-AC25-D50825C4F494 Q39995744-1DB4C539-0822-47A3-B961-D9A18C0CB295

P2860

Is intravesical chemotherapy for superficial bladder cancer still justified?

http://www.wikidata.org/entity/Q36253605

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

2005年论文

@zh

2005年论文

@zh-cn

name

Is intravesical chemotherapy for superficial bladder cancer still justified?

@ast

Is intravesical chemotherapy for superficial bladder cancer still justified?

@en

type

label

Is intravesical chemotherapy for superficial bladder cancer still justified?

@ast

Is intravesical chemotherapy for superficial bladder cancer still justified?

@en

prefLabel

Is intravesical chemotherapy for superficial bladder cancer still justified?

@ast

Is intravesical chemotherapy for superficial bladder cancer still justified?

@en

P1433

Q36253605-E83256FA-39E0-4EFB-9A39-84DBCFA57295

P1476

Q36253605-C3092A80-F5C2-4DB2-A28E-4712FA981B76

P2093

Q36253605-14D11644-D80C-4218-A5B2-235B8ECCEEBD

Q36253605-9D7E8320-2942-4802-BEDE-054E82B07D1E

Q36253605-E1EF1818-35C3-4EA8-88C4-116D8AB3D8AC

Q36253605-EF4AD7A3-BA17-4901-9603-851D5295EF29

P2860

Q36253605-40CFF185-B0D1-4331-8946-E92758ED3D27

Q36253605-4B5E62D6-332E-4343-84BD-BD8E6E1BC37E

Q36253605-59A073F1-D085-49AB-A6D5-BAE4AD918B80

Q36253605-781FACDA-62C9-43A9-98D1-F0C1616FDB45

Q36253605-8165F932-64F3-4809-9F3B-65D4EECAFFB8

Q36253605-82DB95BA-6058-4909-915F-43538F4940C3

Q36253605-A1FC3588-62B3-4B10-9051-F41CB0259F4D

Q36253605-AF9767BF-A440-4343-A59A-E4F4B83DFE94

P304

Q36253605-0C9E9852-1F6F-438B-92C2-96BB7BE27959

P31

Q36253605-8B048FDC-D1FF-4E38-B0D9-3FBCF48C479C

P356

Q36253605-5A3A7E88-0094-4A16-8EFC-00BB907D0A51

P433

Q36253605-17860500-E280-40BF-9295-0DCAB538BCC0

P478

Q36253605-2412088F-A4DE-4426-B78A-F520A40E44C2

P577

Q36253605-D7425987-D69D-4097-8492-0519C27BEA6A

P698

Q36253605-170AD55A-0135-4500-929C-FA2C258CC595

P921

Q36253605-0EB5FA52-43CD-4274-AB02-4AE3BE7076C0

P356

J.1464-410X.2005.05711.X

P1433

BJU International

P1476

Is intravesical chemotherapy for superficial bladder cancer still justified?

@en

P2093

Aloysius A Okeke

http://www.w3.org/2001/XMLSchema#string

David A Gillatt

http://www.w3.org/2001/XMLSchema#string

Hartwig Schwaibold

http://www.w3.org/2001/XMLSchema#string

John L Probert

http://www.w3.org/2001/XMLSchema#string

P2860

Bladder cancer clinical guidelines panel summary report on the management of nonmuscle invasive bladder cancer (stages Ta, T1 and TIS). The American Urological Association.

Immune mechanisms in bacillus Calmette-Guerin immunotherapy for superficial bladder cancer.

Apparent failure of current intravesical chemotherapy prophylaxis to influence the long-term course of superficial transitional cell carcinoma of the bladder.

Intravesical instillation of epirubicin, bacillus Calmette-Guerin and bacillus Calmette-Guerin plus isoniazid for intermediate and high risk Ta, T1 papillary carcinoma of the bladder: a European Organization for Research and Treatment of Cancer geni

The treated natural history of high risk superficial bladder cancer: 15-year outcome.

Randomized intergroup comparison of bacillus calmette-guerin immunotherapy and mitomycin C chemotherapy prophylaxis in superficial transitional cell carcinoma of the bladder a southwest oncology group study.

Impact of intravesical chemotherapy versus BCG immunotherapy on recurrence of superficial transitional cell carcinoma of the bladder: metaanalytic reevaluation.

Intravesical bacille Calmette-Guérin versus mitomycin C in superficial bladder cancer: formal meta-analysis of comparative studies on tumor progression.

P304

763-767

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1464-410X.2005.05711.X

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

96

http://www.w3.org/2001/XMLSchema#string

P577

2005-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16153195

http://www.w3.org/2001/XMLSchema#string

P921